After transforming the treatment of diabetes and weight loss, a growing body of research is raising the possibility that these drugs may help protect against cancer.
Read More
Trial patients who received the drug after surgery or radiation therapy experienced an 83% reduction in the risk of disease recurrence or death compared with those who received a placebo.
Read More
Cancer specialists not involved in the new research expressed optimism that this may be a turning point in the quest for new options.
The treatment uses a combination of two drugs to battle the cancer in addition to surgery to remove tumors.
Ovarian cancer is the fifth-leading cause of cancer death among women in the United States.
Indianapolis-based Roche Diagnostics said while the survey was conducted in Europe, its implications are global and reflect challenges in the United States.
New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north-side warehouse transformed with $160 million into a clean-room manufacturing site for radiopharmaceutical cancer therapies.
The event, a partnership between the tissue bank and the city’s WNBA All-Star 2025 Host Committee, seeks 500 women to donate breast tissue for cancer research.
The Franciscan Healthy Living Center, which opened in 2020, is designed to help those who’ve been through cancer, heart disease, surgery or other serious conditions improve their health factors, including diet, fitness, sleep and mental health.
The findings were released Thursday by the American Society of Clinical Oncology and will be discussed at its annual meeting.
The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of access, past trauma or embarrassment.
The Carmel center, which opened Monday, has 17 infusion rooms, eight rooms for clinical visits, a procedure room and a pharmacy.
Bayer, which acquired Monsanto in 2018, has continued to dispute claims that Roundup causes cancer. But the company has been hit with more than 177,000 lawsuits involving the weedkiller and set aside $16 billion to settle cases.
Indianapolis has been awash in Big Ten logos amid the conference’s basketball tournaments. But Indy is home to another sort of Big Ten gathering—one focused on improving cancer research.
The Indianapolis-based drugmaker will acquire Scorpion’s STX-478, a once-daily oral treatment in early trials for breast cancer and other advanced solid tumors.
The Indianapolis-based hospital system wants to add 34,645 square feet to its MD Anderson Cancer Center at 7979 Shadeland Ave., on the Community Hospital North campus.
The test isn’t a replacement for colonoscopies, but provides a noninvasive approach to screening.
The study followed a group of testicular cancer survivors for an average of 14 years, revealing that 78% experience significant difficulties in everyday listening situations.
At issue is whether a drug developed by Point Biopharma, based in Indianapolis, infringed on a patent issued in 2020 and assigned to Purdue Research Foundation.
Novartis Manufacturing LLC told a committee of the City-County Council on Monday evening that it plans to spend up to $125 million to construct and equip a 79,000-square-foot-building for radiopharmaceutical manufacturing and distribution on the city’s west side.
Following a $45 million renovation, RayzeBio plans to use the plant to make Actinium 225, a radioisotope used for targeted therapy for cancer.
Walther will provide a one-for-one match for donors who establish endowed children’s cancer research funds at Riley Children’s Foundation, a move that could result in at least $20 million for research of new treatments of children’s cancers.
